<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000322131">
  <TermName>alanosine</TermName>
  <TermPronunciation>(uh-LAN-oh-seen)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called antimetabolites. Also called SDX-102.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731184" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;alanosine&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731185" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;alanosina&quot;" language="es" id="_4"/>
  <SpanishTermName>alanosina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de antimetabolito. También se llama SDX-102.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-07-26</DateFirstPublished>
</GlossaryTerm>
